Article
San Francisco - Confirming a diagnosis and individualizing treatment are primary goals in the treatment of patients with cutaneous T cell lymphoma (CTCL), as is striving for complete remission, Eric C. Vonderheid, M.D., said at the annual meeting of the American Academy of Dermatology.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.